相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does Fgf23-klotho activity influence vascular and soft tissue calcification through regulating mineral ion metabolism?
Fahad Memon et al.
KIDNEY INTERNATIONAL (2008)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Dynamics of parathyroid hormone secretion in health and secondary hyperparathyroidism
Arnold J. Felsenfeld et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis
Shoji Ichikawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The emerging role of the fibroblast growth factor-23-Klotho axis in renal regulation of phosphate homeostasis
Mohammed S. Razzaque et al.
JOURNAL OF ENDOCRINOLOGY (2007)
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization
Shiguang Liu et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2007)
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members
Regina Goetz et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
The collagen-specific molecular chaperone HSP47: is there a role in fibrosis?
Takashi Taguchi et al.
TRENDS IN MOLECULAR MEDICINE (2007)
New aspect of renal phosphate reabsorption: The type IIc sodium-dependent phosphate transporter
Ken-Ichi Miyamoto et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men
Diana M. Antoniucci et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Association of disorders in mineral metabolism with progression of chronic kidney disease
Stephan Schwarz et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Hypervitaminosis D and premature aging:: lessons learned from Fgf23 and Klotho mutant mice
Mohammed S. Razzaque et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process
MS Razzaque et al.
FASEB JOURNAL (2006)
Hypophosphatemia: An update on its etiology and treatment
A Gaasbeek et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Structural and biochemical properties of fibroblast growth factor 23
T Yamashita
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease
O Gutierrez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
FGF23 and disorders of phosphate homeostasis
XJ Yu et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients
S Nakanishi et al.
KIDNEY INTERNATIONAL (2005)
Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men
SL Ferrari et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia
A Benet-Pagès et al.
HUMAN MOLECULAR GENETICS (2005)
Circulating FGF-23 is regulated by 1α,25-dihydroxyvitamin D3 and phosphorus in vivo
H Saito et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism
H Nishi et al.
NEPHRON CLINICAL PRACTICE (2005)
Fibroblast growth factor 23: Roles in health and disease
EA Imel et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
FGF-23 in patients with end-stage renal disease on hemodialysis
Y Imanishi et al.
KIDNEY INTERNATIONAL (2004)
Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression
K Takeshita et al.
CIRCULATION (2004)
FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis
T Shimada et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa
T Shimada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
AS Go et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis
GA Block et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders
XY Bai et al.
ENDOCRINOLOGY (2004)
Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
T Larsson et al.
KIDNEY INTERNATIONAL (2003)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Severely reduced production of Klotho in human chronic renal failure kidney
N Koh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23
KE White et al.
NATURE GENETICS (2000)
分享论文
